Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides
Sk. Abdul Amin, Nilanjan Adhikari, Sonali Kotagiri, et al.
European Journal of Medicinal Chemistry (2019) Vol. 166, pp. 369-380
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors
Goverdhan Lanka, Darakhshan Begum, Suvankar Banerjee, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107481-107481
Closed Access | Times Cited: 59
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
Rajat Sarkar, Suvankar Banerjee, Sk. Abdul Amin, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112171-112171
Closed Access | Times Cited: 100
Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer
Sravani Pulya, Ambati Himaja, Milan Paul, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12033-12058
Closed Access | Times Cited: 30
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
Mengchen Xu, Yiming Hou, Na Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities
Daniel A. Rodrigues, Pedro de Sena Murteira Pinheiro, Fernanda S. Sagrillo, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2177-2211
Closed Access | Times Cited: 56
Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
Nilanjan Adhikari, Tarun Jha, Balaram Ghosh
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8827-8869
Closed Access | Times Cited: 46
Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer
Sravani Pulya, Tarun Patel, Milan Paul, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114470-114470
Closed Access | Times Cited: 28
Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation
Navanath Kumbhar, Snehal Nimal, Sagar S. Barale, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Histone deacetylase 3 in hippocampus contributes to memory impairment after chronic constriction injury of sciatic nerve in mice
Guang-Fen Zhang, Zhiqiang Zhou, Jie Guo, et al.
Pain (2020) Vol. 162, Iss. 2, pp. 382-395
Closed Access | Times Cited: 38
Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease
Xuewen Xiao, Xixi Liu, Bin Jiao
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 38
HDAC3 inhibitors: a patent review of their broad-spectrum applications as therapeutic agents
Thabo Brighton Makgoba, Erika Kapp, Samuel Egieyeh, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 4, pp. 273-295
Open Access | Times Cited: 4
Genes associated with cognitive performance in the Morris water maze: an RNA-seq study
Vasiliy Reshetnikov, Polina E. Kisaretova, Nikita Ershov, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 30
Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105050-105050
Closed Access | Times Cited: 24
Upregulation of HDAC3 mediates behavioral impairment in the bile duct ligation model of hepatic encephalopathy
Shiwangi Gupta, Vikas Rishi, Pavani Elipilla, et al.
International Journal of Biological Macromolecules (2025), pp. 141596-141596
Closed Access
Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation
Ambati Himaja, Ganesh Routholla, Tarun Patel, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117636-117636
Closed Access
HDAC3 inhibition mitigates acute kidney injury by alleviating RIPK1-mediated programmed necrosis
Manman Xie, Rui Hou, Run-run Shan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Exploring different classification-dependent QSAR modelling strategies for HDAC3 inhibitors in search of meaningful structural contributors
Tarun Jha, Rajkumar Jana, Suvankar Banerjee, et al.
SAR and QSAR in environmental research (2024) Vol. 35, Iss. 5, pp. 367-389
Closed Access | Times Cited: 3
Histone deacetylases 1, 2 and 3 in nervous system development
Santosh R. D’Mello
Current Opinion in Pharmacology (2020) Vol. 50, pp. 74-81
Closed Access | Times Cited: 22
PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model
Sravani Pulya, Ashutosh Mahale, Yamini Bobde, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 5, pp. 883-892
Closed Access | Times Cited: 20
Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105446-105446
Closed Access | Times Cited: 20
Postmortem Brains from Subjects with Diabetes Mellitus Display Reduced GLUT4 Expression and Soma Area in Hippocampal Neurons: Potential Involvement of Inflammation
Caio Yogi Yonamine, Marisa Passarelli, Cláudia Kimie Suemoto, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1250-1250
Open Access | Times Cited: 8
An Antisense Oligonucleotide Leads to Suppressed Transcription of Hdac2 and Long-Term Memory Enhancement
Shane G. Poplawski, Krassimira Garbett, Rebekah L. McMahan, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 19, pp. 1399-1412
Open Access | Times Cited: 18
RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation
Hetao Bian, Ling Xiao, Liang Liang, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108259-108259
Closed Access | Times Cited: 14
Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats
Mahshid Badrikoohi, Aghil Esmaeili-Bandboni, Parvin Babaei
Brain Research Bulletin (2021) Vol. 179, pp. 49-56
Closed Access | Times Cited: 13
Bacosides Encapsulated in Lactoferrin Conjugated PEG-PLA-PCL-OH Based Polymersomes Act as Epigenetic Modulator in Chemically Induced Amnesia
Kritika Goyal, Arpita Konar, Ashish Kumar, et al.
Neurochemical Research (2020) Vol. 45, Iss. 4, pp. 796-808
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top